MedPlus Health Services Limited (NSE:MEDPLUS)

MedPlus Health Services Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	71,847	100,834	90,967	82,223	77,513	121,036
Market Cap Growth	-20.04%	10.85%	10.63%	6.08%	-35.96%	-
Enterprise Value	81,755	106,712	98,583	89,837	81,173	126,771
Last Close Price	598.05	839.90	760.00	687.85	649.70	1014.50

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	33.92	45.92	60.55	125.58	155.76	126.34
Forward PE	33.34	42.61	48.95	83.56	101.15	82.82
PS Ratio	0.95	1.46	1.48	1.46	1.70	3.20
PB Ratio	3.47	5.11	5.23	5.21	5.20	8.54
P/TBV Ratio	3.56	5.24	5.38	5.39	5.38	8.83
P/FCF Ratio	38.89	27.07	18.91	138.57	-	232.01
P/OCF Ratio	20.98	20.35	16.83	57.20	85.74	71.24
PEG Ratio	1.75	1.85	1.06	1.25	3.26	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.08	1.55	1.61	1.60	1.78	3.35
EV/EBITDA Ratio	12.53	25.58	30.44	43.10	57.51	67.89
EV/EBIT Ratio	23.64	31.22	39.40	63.15	84.48	77.91
EV/FCF Ratio	44.25	28.64	20.50	151.40	-	243.01

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.75	0.72	0.64	0.64	0.60	0.57
Debt / EBITDA Ratio	2.37	2.29	2.26	2.77	3.26	2.90
Debt / FCF Ratio	8.38	3.82	2.33	17.01	-	15.62
Net Debt / Equity Ratio	0.48	0.42	0.39	0.54	0.45	0.56
Net Debt / EBITDA Ratio	2.32	2.00	2.10	4.05	4.76	4.25
Net Debt / FCF Ratio	5.37	2.23	1.41	14.23	-8.54	15.21
Asset Turnover	1.96	1.89	1.93	1.94	1.69	1.82
Inventory Turnover	4.05	3.75	3.48	3.55	3.47	3.60
Quick Ratio	0.78	0.93	0.80	0.36	0.51	0.10
Current Ratio	2.83	3.00	3.20	2.98	3.11	2.92
Return on Equity (ROE)	10.79%	11.82%	9.05%	4.28%	3.45%	8.82%
Return on Assets (ROA)	5.56%	5.86%	4.91%	3.06%	2.23%	4.89%
Return on Invested Capital (ROIC)	9.40%	10.43%	8.47%	5.54%	4.40%	7.63%
Return on Capital Employed (ROCE)	10.10%	10.50%	9.00%	5.70%	4.10%	8.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.95%	2.18%	1.65%	0.80%	0.64%	0.79%
FCF Yield	2.57%	3.69%	5.29%	0.72%	-1.01%	0.43%
Buyback Yield / Dilution	0.23%	-0.06%	0.00%	-0.31%	-6.38%	-3.82%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error